acquisition
Exclusive: Cancer drugmaker Tesaro attracts takeover interest – sources
February 8, 2017 by publisher · Leave a Comment
The takeover interest in Tesaro underscores the pharmaceutical industry's strong appetite for the acquisition of biotechnology companies with promising medicines under development in lucrative sectors such as cancer treatment. Tesaro is not actively exploring a sale, the people said this week, noting that there is a significant gap over the company's valuation between Tesaro and potential acquirers.
Read the original:
Exclusive: Cancer drugmaker Tesaro attracts takeover interest – sources
acquisition
France’s Amundi to buy Pioneer from UniCredit for $3.75 billion
December 12, 2016 by publisher · Leave a Comment
French fund management company Amundi is to buy asset manager Pioneer from Italian bank UniCredit for 3.55 billion euros ($3.75 billion), and will finance the deal with a debt and equity issue. The deal is one of various disposals being pursued…
Read the original post:
France’s Amundi to buy Pioneer from UniCredit for $3.75 billion